Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer

Els Berns, Jan Klijn, Maxime Look, N Grebenchtchikov, R Vossen, HAAM (Harry) Peters, A Geurts-Moespot, H (Henk) Portengen, I Staveren, M Meijer - Gelder, B Bakker, FCGJ Sweep, John Foekens

Research output: Contribution to journalArticleAcademicpeer-review

66 Citations (Scopus)
6 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)1253-1258
Number of pages6
JournalClinical Cancer Research
Publication statusPublished - 2003

Research programs

  • EMC MM-03-86-01

Cite this